596 related articles for article (PubMed ID: 9886517)
41. Levonorgestrel implant use among adolescents.
Mashburn M
J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
[TBL] [Abstract][Full Text] [Related]
42. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
43. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
[TBL] [Abstract][Full Text] [Related]
44. Contraceptive implant use among inner city teens.
Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
[TBL] [Abstract][Full Text] [Related]
45. Norplant subdermal contraceptive system: experience in Taiwan.
Tseng LH; Lee TY; Yang YS; Ko TM; Chuang SM
Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
[TBL] [Abstract][Full Text] [Related]
46. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
47. Acceptability of Norplant implants for fertility regulation in Singapore.
Singh K; Viegas OA; Fong YF; Ratnam SS
Contraception; 1992 Jan; 45(1):39-47. PubMed ID: 1591920
[TBL] [Abstract][Full Text] [Related]
48. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
[TBL] [Abstract][Full Text] [Related]
49. Norplant use among urban minority women in the United States.
Glantz S; Glantz JC; Campbell-Heider N; Schaff E
Contraception; 2000 Feb; 61(2):83-90. PubMed ID: 10802272
[TBL] [Abstract][Full Text] [Related]
50. Experience with side effects and health risks associated with Norplant implant use in adolescents.
Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL
Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
[TBL] [Abstract][Full Text] [Related]
51. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
[TBL] [Abstract][Full Text] [Related]
52. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Power J; French R; Cowan F
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
[TBL] [Abstract][Full Text] [Related]
53. Levonorgestrel subdermal implants (Norplant) for long-term contraception.
Sharts-Engel NC
MCN Am J Matern Child Nurs; 1991; 16(4):232. PubMed ID: 1943533
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and continuation rates of Norplant in Pakistan.
Rehan N; Inayatullah A; Chaudhary I
Contraception; 1999 Jul; 60(1):39-43. PubMed ID: 10549451
[TBL] [Abstract][Full Text] [Related]
55. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
56. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.
Grubb GS; Moore D; Anderson NG
Contraception; 1995 Nov; 52(5):287-96. PubMed ID: 8585885
[TBL] [Abstract][Full Text] [Related]
57. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
58. Preliminary experience with Norplant in an inner city population.
Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
[TBL] [Abstract][Full Text] [Related]
59. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
